David A. Estevez-Bernal
Bogota, DC, Colombia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The role of pluripotency regulators in triple-negative breast cancer immune response.
Journal: Frontiers in genetics
Published: December 19, 2025
Personalized medicine in triple-negative breast cancer: combining neoantigen vaccination and genomic profiling in a patient undergoing neoadjuvant chemotherapy.
Journal: Frontiers in oncology
Published: May 05, 2025
Cationic antimicrobial peptides: potential templates for anticancer agents.
Journal: Frontiers in medicine
Published: December 19, 2024
Neoadjuvant chemotherapy modulates exhaustion of T cells in breast cancer patients.
Journal: PloS one
Published: July 27, 2022
The breast cancer immune microenvironment is modified by neoadjuvant chemotherapy.
Journal: Scientific reports
Published: October 21, 2021
Young but not older adults exhibit an expansion of CD45RA+CCR7+CD95+ T follicular helper cells in response to tetanus vaccine.
Journal: Experimental gerontology
Published: June 04, 2021
Autologous Dendritic Cells in Combination With Chemotherapy Restore Responsiveness of T Cells in Breast Cancer Patients: A Single-Arm Phase I/II Trial.
Journal: Frontiers in immunology
Published: February 19, 2021
Usefulness of IL-21, IL-7, and IL-15 conditioned media for expansion of antigen-specific CD8+ T cells from healthy donor-PBMCs suitable for immunotherapy.
Journal: Cellular immunology
Published: May 08, 2020
Monitoring the responsiveness of T and antigen presenting cell compartments in breast cancer patients is useful to predict clinical tumor response to neoadjuvant chemotherapy.
Journal: BMC cancer
Published: January 16, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026